Estrogenic activity of surface waters using zebrafish- and human-based in vitro assays: The Danube as a case-study.


Journal

Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 09 01 2020
revised: 18 04 2020
accepted: 22 04 2020
pubmed: 18 5 2020
medline: 5 1 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

Most in vitro reporter gene assays used to assess estrogenic contamination are based on human estrogen receptor α (hERα) activation. However, fish bioassays can have distinct response to estrogenic chemicals and mixtures, questioning the relevance of human-based bioassays for assessing risk to this species. In this study, zebrafish liver cells stably expressing zebrafish ERβ2 (ZELHβ2) and human breast cancer cells expressing hERα (MELN) were used to quantify the estrogenic activity of 25 surface water samples of the Danube River, for which chemicals have been previously quantified. Most samples had a low estrogenic activity below 0.1 ng/L 17β-estradiol-equivalents that was more often detected by MELN cells, while ZELHβ2 response tend to be lower than predicted based on the chemicals identified. Nevertheless, both bioassays quantified well a higher estrogenic activity at two sites, which was confirmed in vivo using a transgenic zebrafish assay. The results are discussed considering the effect-based trigger values proposed for water quality monitoring.

Identifiants

pubmed: 32417722
pii: S1382-6689(20)30077-6
doi: 10.1016/j.etap.2020.103401
pii:
doi:

Substances chimiques

ESR1 protein, human 0
Estrogen Receptor alpha 0
Estrogen Receptor beta 0
Estrogens 0
Water Pollutants, Chemical 0
Zebrafish Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103401

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Hélène Serra (H)

Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, Institut National de l'Environnement Industriel et des Risques (INERIS), Verneuil-en-Halatte, France; UMR-CNRS EPOC/LPTC, Université de Bordeaux, Talence, France.

François Brion (F)

Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, Institut National de l'Environnement Industriel et des Risques (INERIS), Verneuil-en-Halatte, France.

Clémence Chardon (C)

Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, Institut National de l'Environnement Industriel et des Risques (INERIS), Verneuil-en-Halatte, France.

Hélène Budzinski (H)

UMR-CNRS EPOC/LPTC, Université de Bordeaux, Talence, France.

Tobias Schulze (T)

UFZ, Helmholtz Centre for Environmental Research, Leipzig, Germany.

Werner Brack (W)

UFZ, Helmholtz Centre for Environmental Research, Leipzig, Germany; RWTH Aachen University, Aachen, Germany.

Selim Aït-Aïssa (S)

Unité Ecotoxicologie in vitro et in vivo, UMR-I 02 SEBIO, Institut National de l'Environnement Industriel et des Risques (INERIS), Verneuil-en-Halatte, France. Electronic address: selim.ait-aissa@ineris.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH